当前位置: X-MOL 学术FEMS Yeast Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dear medical mycologists, it is time to look outside the box.
FEMS Yeast Research ( IF 3.2 ) Pub Date : 2020-02-01 , DOI: 10.1093/femsyr/foz080
Florent Morio 1, 2
Affiliation  

Opulente et al. (Opulente DA, Langdon QK, Buh KV et al. Pathogenic budding yeasts isolated outside of clinical settings. FEMS Yeast Res 2019;19:foz032) published early this year a study aiming to investigate the diversity of wild yeast species, by collecting 1000 environmental samples coming from different substrates across the United States of America. The main finding of this work is the recovery of 54 strains of budding yeasts of which several are having a pathogenic potential in the clinical setting, such as Candida albicans, C. parapsilosis, C. tropicalis, Nakaseomyces glabrata and Pichia kudriavzevii. These findings, discussed here in light of other recent studies highlighting the role of fungicides in the rise of antifungal resistance in the clinical setting or the emergence of Candida auris, demonstrate that our environment can represent an alternative niche for several opportunistic fungal pathogens that can be a concern for human health.

中文翻译:

尊敬的医学真菌学家,该是时候打破常规了。

Opulente等。(Opulente DA,Langdon QK,Buh KV等人。在临床环境之外分离出致病性发芽酵母.FEMS Yeast Res 2019; 19:foz032)今年初发布了一项研究,旨在通过收集1000种环境来研究野生酵母物种的多样性样品来自美国各地。这项工作的主要发现是回收了54株发芽酵母菌株,其中有几株在临床环境中具有致病潜力,例如白色念珠菌,副产念珠菌,热带念珠菌,光滑的纳卡氏菌和库德毕赤酵母。这些发现是根据最近的其他研究进行讨论的,这些研究着重强调了杀菌剂在临床环境中或耳道念珠菌的出现中在抗真菌耐药性上升中的作用,
更新日期:2019-11-01
down
wechat
bug